Wolverine Asset Management LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Wolverine Asset Management LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $3,654 - $4,866	100 New	100 $4,000
Q1 2022 May 04, 2022	SELL	$29.88 - $37.04 $89,640 - $111,120	-3,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $76,518 - $114,804	-1,800 Reduced 37.5%	3,000 $134,000
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $142,350 - $188,850	3,000 Added 166.67%	4,800 $227,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $96,930 - $117,486	1,800 New	1,800 $108,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $422,212 - $585,752	-6,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $359,856 - $551,956	6,800 New	6,800 $551,000
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $571,473 - $714,870	-14,100 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $1.56 Million - $1.94 Million	-35,300 Reduced 71.46%	14,100 $621,000
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $945,640 - $1.21 Million	-18,800 Reduced 27.57%	49,400 $2.48 Million
Q3 2017 Nov 14, 2017	SELL	$45.56 - $59.57 $473,824 - $619,528	-10,400 Reduced 13.23%	68,200 $3.46 Million
Q2 2017 Aug 14, 2017	BUY	N/A	78,600	78,600 $4 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.